Technical Analysis for GUD - Knight Therapeutics Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Three Weeks Tight | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| 20 DMA Support | Bullish | 0.70% | |
| Hammer Candlestick | Bullish | 0.70% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.70% | |
| Doji - Bullish? | Reversal | 0.70% | |
| Gapped Up | Strength | 0.17% | |
| 180 Bullish Setup | Bullish Swing Setup | -1.04% | |
| NR7 | Range Contraction | -1.04% |
| Alert | Time |
|---|---|
| Up 1 ATR | about 13 hours ago |
| 10 DMA Support | about 13 hours ago |
| Reversed from Up | about 14 hours ago |
| Gap Up Closed | about 16 hours ago |
| 10 DMA Resistance | about 16 hours ago |
Get a Trading Assistant
- Earnings date: 2024-05-09
Knight Therapeutics Inc. Description
Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Marketing Pharma Pharmaceutical Labor Science Life Sciences Pharmaceuticals Pharmaceutical Products Medical Devices Pharmaceutical Industry Pharmaceutical Sciences Consumer Health Products Pharmaceutical Industry In China
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.95 |
| 52 Week Low | 4.35 |
| Average Volume | 71,333 |
| 200-Day Moving Average | 5.091 |
| 50-Day Moving Average | 5.505 |
| 20-Day Moving Average | 5.641 |
| 10-Day Moving Average | 5.765 |
| Average True Range | 0.143 |
| RSI (14) | 55.95 |
| ADX | 24.9 |
| +DI | 28.819 |
| -DI | 20.461 |
| Chandelier Exit (Long, 3 ATRs) | 5.521 |
| Chandelier Exit (Short, 3 ATRs) | 5.659 |
| Upper Bollinger Bands | 6.033 |
| Lower Bollinger Band | 5.248 |
| Percent B (%b) | 0.61 |
| BandWidth | 13.931 |
| MACD Line | 0.087 |
| MACD Signal Line | 0.091 |
| MACD Histogram | -0.0039 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.970 | ||||
| Resistance 3 (R3) | 5.980 | 5.910 | 5.930 | ||
| Resistance 2 (R2) | 5.910 | 5.849 | 5.905 | 5.917 | |
| Resistance 1 (R1) | 5.820 | 5.811 | 5.785 | 5.810 | 5.903 |
| Pivot Point | 5.750 | 5.750 | 5.733 | 5.745 | 5.750 |
| Support 1 (S1) | 5.660 | 5.689 | 5.625 | 5.650 | 5.557 |
| Support 2 (S2) | 5.590 | 5.651 | 5.585 | 5.543 | |
| Support 3 (S3) | 5.500 | 5.590 | 5.530 | ||
| Support 4 (S4) | 5.490 |
